Hyperinsulinemic Euglycemia Therapy for Acute Nitroglycerin Poisoning: Case Report
International Journal of Medical Toxicology and Forensic Medicine,
Vol. 12 No. 2 (2022),
23 May 2022
,
Page 37176
https://doi.org/10.32598/ijmtfm.v12i2.37176
Abstract
Nitroglycerin, a vasodilator, is commonly administered to treat ischemic heart disease. Adverse effects after toxicity are light-headedness, nausea, blurry vision, and syncope due to low systolic blood pressure as well as methemoglobinemia. A 19-year-old female was admitted to our toxicology department after suicidal ingestion of 320 mg extended-release nitroglycerin about 45 minutes before the admission. She was conscious, and her initial blood pressure was 98/65 mm Hg, which was decreased to 77 mmHg within 1.5 hours despite administration of 1 liter of normal saline. Due to severe hypotension, norepinephrine infusion was started for systolic blood pressure maintenance above 80mm Hg; however, she started complaining of palpitation and chest pain. So, the dose of norepinephrine was reduced, and glucose, insulin, and potassium protocol were started. After 3 hours of therapy, her hemodynamic condition stabilized with systolic blood pressure above 90mm Hg; hence norepinephrine was discontinued. She was discharged on the 3rd day after the psychiatric consultation, with regular clinical and paraclinical examinations.
- Nitroglycerin
- Toxicity
- Hypotension
- Hyperinsulinemic euglycemia
How to Cite
References
Kojima S, Matsui K, Sakamoto T, Ishihara M, Kimura K, Miyazaki S, et al. Long-term nitrate therapy after acute myocardial infarction does not improve or aggravate prognosis. Circulation Journal. 2007; 71(3):301-7. [DOI:10.1253/circj.71.301] [PMID]
Kim KH, Kerndt CC, Adnan G, Schaller DJ. Nitroglycerin. StatPearls [Internet]; 2021. https://www.ncbi.nlm.nih.gov/books/NBK482382/#article-25900.s5
Katabami K, Hayakawa M, Gando S. Severe methemoglobinemia due to sodium nitrite poisoning. Case Reports in Emergency Medicine. 2016; 2016:9013816. [DOI:10.1155/2016/9013816] [PMID] [PMCID]
Panahi Y, Pishgoo B, Dadjou Y, Mehdirad M, Soflaei SS, Sahebkar A. Efficacy and safety of Dorocontin® versus Sustac® in the treatment of stable Angina Pectoris: A randomized, double-blind comparative trial. Scientia Pharmaceutica. 2014; 82(4):815-24. [DOI:10.3797/scipharm.1406-16] [PMID] [PMCID]
Muniyappa R, Sowers JR. Role of insulin resistance in endothelial dysfunction. Reviews in Endocrine and Metabolic Disorders. 2013; 14(1):5-12. [DOI:10.1007/s11154-012-9229-1] [PMID] [PMCID]
Sunouchi T, Suzuki K, Nakayama K, Ishikawa T. Dual effect of nitric oxide on ATP-sensitive K+ channels in rat pancreatic β cells. Pflügers Archiv: European Journal of Physiology. 2008; 456(3):573-9. [DOI:10.1007/s00424-008-0463-z] [PMID]
Agarwal A, Yu SW, Rehman A, Henkle JQ. Hyperinsulinemia euglycemia therapy for calcium channel blocker overdose: A case report. Texas Heart Institute Journal. 2012; 39(4):575-8. [PMCID]
Mégarbane B, Karyo S, Baud FJ. The role of insulin and glucose (hyperinsulinaemia/euglycaemia) therapy in acute calcium channel antagonist and β-blocker poisoning. Toxicological Reviews. 2004; 23(4):215-22. [DOI:10.2165/00139709-200423040-00002] [PMID]
Ding Y, Vaziri ND. Calcium channel blockade enhances nitric oxide synthase expression by cultured endothelial cells. Hypertension. 1998; 32(4):718-23. [DOI:10.1161/01.HYP.32.4.718] [PMID]
Conti V, Russomanno G, Corbi G, Izzo V, Vecchione C, Filippelli A. Adrenoreceptors and nitric oxide in the cardiovascular system. Frontiers in Physiology. 2013; 4:321. [DOI:10.3389/fphys.2013.00321]
Hoffman RS, Howland MA, Levin NA, Nelson LS, Goldfrank LR. Goldfrank’s toxicologic emergencies. 10th ed. New York: Mc Graw Hill Publishing; 2014. https://books.google.com/books/about/Goldfrank_s_Toxicologic_Emergencies_Tent.html?id=hTcfBQAAQBAJ
Davis JW, Shackford SR, Mackersie RC, Hoyt DB. Base deficit as a guide to volume resuscitation. The Journal of Trauma. 1988; 28(10):1464-7. [DOI:10.1097/00005373-198810000-00010] [PMID]
Smith SW, Ferguson KL, Hoffman RS, Nelson LS, Greller HA. Prolonged severe hypotension following combined amlodipine and valsartan ingestion. Clinical Toxicology. 2008; 46(5):470-4. [DOI:10.1080/15563650701779695] [PMID]
Lenasi H, Kohlstedt K, Fichtlscherer B, Mulsch A, Busse R, Fleming I. Amlodipine activates the endothelial nitric oxide synthase by altering phosphorylation on Ser1177 and Thr495. Cardiovascular Research. 2003; 59(4):844-53. [DOI:10.1016/S0008-6363(03)00505-4]
Koskenkari JK, Kaukoranta PK, Kiviluoma KT, Raatikainen MP, Ohtonen PP, Ala-Kokko TI. Metabolic and hemodynamic effects of high-dose insulin treatment in aortic valve and coronary surgery. The Annals of Thoracic Surgery. 2005; 80(2):511-7. [DOI:10.1016/j.athoracsur.2005.03.024] [PMID]
Doenst T, Bothe W, Beyersdorf F. Therapy with insulin in cardiac surgery: Controversies and possible solutions. The Annals of Thoracic Surgery. 2003; 75(2):S721-8 [DOI:10.1016/S0003-4975(02)04698-2]
- Abstract Viewed: 502 times
- pdf Downloaded: 330 times